Sven Rottenberg - Curriculum Vitae#
EDUCATION
- 2004 Diploma of the European College of Veterinary Pathologists (ECVP)
- 2003 PhD, Vetsuisse Faculty of the Universities Bern and Zürich, Switzerland
- 2000 Doctor of Veterinary Medicine (DVM), University of Bern, Switzerland
- 1997 Diploma (“Staatsexamen”) in Veterinary Medicine, Free University of Berlin, Germany
EMPLOYMENT HISTORY INCLUDING CURRENT POSITION
- 2014 Director of the Institute of Animal Pathology, Vetsuisse, University of Bern
- 2012 - 2014 Group leader (assoc. professor), The Netherlands Cancer Institute (NKI), Amsterdam
- 2010 - 2012 Associate staff scientist, Molecular Biology, NKI, Amsterdam
- 2007 - 2010 Senior postdoctoral fellow, Molecular Biology, NKI, Amsterdam
- 2004 - 2007 Postdoctoral fellow, Molecular Biology, NKI, Amsterdam
- 1999 - 2004 Combined residency/PhD program, Institute of Animal Pathology, University of Bern
- 1998 - 1999 Resident in Domestic Animal Sciences, University of Kiel, Germany
INSTITUTIONAL RESPONSIBILITIES
- 2024 President, Hans Sigrist Foundation of the University of Bern
- 2019 Vice dean, Vetsuisse Faculty, University of Bern
- 2017 Chair, Department of Infectious Diseases and Pathobiology, University of Bern
APPROVED RESEARCH PROJECTS AS LEADING INVESTIGATOR (LAST 5 YEARS)
- 2024 Novartis Foundation for Biomedical Research: Establishing biomarkers to predict platinum drug response; CHF 80,000
- 2023 - 2027 SNSF co-investigator grant with J. Jonkers (NKI)(320030M_219453): Mechanisms of HRindependent chemoresistance in BRCA1/2-mutated tumors; CHF 960,000
- 2022 - 2026 Swiss Cancer League (KFS-5519-02-2022): Targeting platinum drug resistance; CHF 374,500
- 2022 - 2026 Ovarian Cancer Research Program, US Department of Defence (OC210104): Targeting PARPi resistance; USD 400,000
- 2021 - 2025 SNSF Sinergia grant (CRSII5_198543): Functional chemoinformatic modelling of the host cell metabolome to fight apicomplexan parasites; CHF 690,538
- 2019 - 2023 SNSF grant (310030_189127): Identifying the essentialome of Theileria-induced host cell transformation; CHF 374,009
- 2019 - 2021 Wilhelm Sander-Stiftung: Cancer therapy resistance: alterations in the DNA repair as underlying mechanism; 177,000 EUR
- 2018 - 2022 SNSF grant (310030_179360): Mechanisms of PARP inhibitor resistance that are independent of restoration of homology-directed DNA repair; CHF 879,509
- 2018 - 2022 Swiss Cancer League (KLS-4282-08-2017): Understanding the role of the CST complex in the synth. lethal interaction between BRCA1 def. and PARPi; CHF 330,000
SUPERVISION OF JUNIOR RESEARCHERS (MAIN SUPERVISOR, SINCE 2007)
8 senior postdocs, 9 early postdocs, 27 PhD students (21 finished, 6 ongoing), 23 master students
